Free Trend Report Free 2018 Report & eBook

Get the top 100 trends happening right NOW -- plus a FREE copy of our award-winning book.

Keynotes.org Our Research Methodology

This article is one of 350,000 experiments. We use crowd filtering, big data and AI to identify insights.

A New Asthma Treatment was Developed with Increased Efficacy Rates

 - Feb 9, 2018
References: rutgers.edu & newatlas
Some children and adults who are suffering with asthma because of an inability to take certain medications will be excited to hear the news of a new asthma treatment that is being researched by scientists.

The drug was developed by scientists from the Rutgers New Jersey Medical School and the Shanghai University, and has been shown to offer advanced relief from asthma. Known as metallothionein-2 (MT-2), the protein occurs naturally in the body and is shown to be available in decreased amounts amongst those who have asthma. It was discovered that an MT-2-based drug known as 'TSG12' was able to provide increased breathing abilities amongst mice with efficacy being more effective than inhalers. The new asthma treatment has been proved to be non-toxic for human cells, which is supporting the next step in the development process that focuses on clinical trials.

Image Credit: Depositphotos